Evidence map›Paper›PMID 35697783›Full record

ArticleNature cell biology2022

Integrated multi-omics reveal polycomb repressive complex 2 restricts human trophoblast induction.

Dick W Zijlmans, Irene Talon, Sigrid Verhelst, Adam Bendall, Karlien Van Nerum, Alok Javali, Andrew A Malcolm, Sam S F A van Knippenberg, Laura Biggins, San Kit To and 27 more

Open access · hybridAbstract read
In one paragraph

Article in Nature cell biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
6.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 72 citations in OpenAlex.

  1. An Integrated Proteomics and Genomics Approach to Identify Essential Protein Kinases During Human Trophoblast Development.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. VGLL1 contributes to both the transcriptome and epigenome of the developing trophoblast compartment.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

37 authors at 8 institutions in 5 countries.

Dick W Zijlmans *Department of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences (RIMLS), Oncode Institute, Radboud University Nijmegen, Nijmegen, The Netherlands.
Irene Talon *Department of Development and Regeneration, Leuven Stem Cell Institute, Leuven Institute for Single Cell Omics (LISCO), KU Leuven, Leuven, Belgium.ORCID http://orcid.org/0000-0002-5800-5555
Sigrid Verhelst *ProGenTomics, Laboratory of Pharmaceutical Biotechnology, Ghent University, Ghent, Belgium.ORCID http://orcid.org/0000-0002-6791-3782
Adam Bendall *Epigenetics Programme, Babraham Institute, Cambridge, UK.ORCID http://orcid.org/0000-0002-6865-2625
Karlien Van NerumDepartment of Development and Regeneration, Leuven Stem Cell Institute, Leuven Institute for Single Cell Omics (LISCO), KU Leuven, Leuven, Belgium.ORCID http://orcid.org/0000-0002-8952-5473
Alok JavaliInstitute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria.
Andrew A MalcolmEpigenetics Programme, Babraham Institute, Cambridge, UK.ORCID http://orcid.org/0000-0001-6240-7701
Sam S F A van KnippenbergDepartment of Development and Regeneration, Leuven Stem Cell Institute, Leuven Institute for Single Cell Omics (LISCO), KU Leuven, Leuven, Belgium.ORCID http://orcid.org/0000-0001-5656-3046
Laura BigginsBioinformatics Group, Babraham Institute, Cambridge, UK.
San Kit ToDepartment of Development and Regeneration, Leuven Stem Cell Institute, Leuven Institute for Single Cell Omics (LISCO), KU Leuven, Leuven, Belgium.ORCID http://orcid.org/0000-0002-3057-2902
Adrian JaniszewskiDepartment of Development and Regeneration, Leuven Stem Cell Institute, Leuven Institute for Single Cell Omics (LISCO), KU Leuven, Leuven, Belgium.
Danielle AdmiraalDepartment of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University Nijmegen, Nijmegen, The Netherlands.
Ruth KnopsLaboratory of Hematology, Department of Laboratory Medicine, Radboud University Nijmegen Medical Centre (RadboudUMC), Nijmegen, the Netherlands.
Nikky CorthoutVIB Center for Brain and Disease Research, KU Leuven, VIB Bioimaging Core, Leuven, Belgium.
Bradley P BalatonDepartment of Development and Regeneration, Leuven Stem Cell Institute, Leuven Institute for Single Cell Omics (LISCO), KU Leuven, Leuven, Belgium.ORCID http://orcid.org/0000-0002-5130-7868
Grigorios GeorgolopoulosDepartment of Development and Regeneration, Leuven Stem Cell Institute, Leuven Institute for Single Cell Omics (LISCO), KU Leuven, Leuven, Belgium.
Amitesh PandaDepartment of Development and Regeneration, Leuven Stem Cell Institute, Leuven Institute for Single Cell Omics (LISCO), KU Leuven, Leuven, Belgium.ORCID http://orcid.org/0000-0002-2702-3494
Natarajan V BhanuEpigenetics Institute, Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Amanda J CollierEpigenetics Programme, Babraham Institute, Cambridge, UK.
Charlene FabianEpigenetics Programme, Babraham Institute, Cambridge, UK.
Ryan N AllsopDepartment of Development and Regeneration, Leuven Stem Cell Institute, Leuven Institute for Single Cell Omics (LISCO), KU Leuven, Leuven, Belgium.
Joel ChappellDepartment of Development and Regeneration, Leuven Stem Cell Institute, Leuven Institute for Single Cell Omics (LISCO), KU Leuven, Leuven, Belgium.
Thi Xuan Ai PhamDepartment of Development and Regeneration, Leuven Stem Cell Institute, Leuven Institute for Single Cell Omics (LISCO), KU Leuven, Leuven, Belgium.ORCID http://orcid.org/0000-0003-3866-2002
Michael OberhuemerDepartment of Development and Regeneration, Leuven Stem Cell Institute, Leuven Institute for Single Cell Omics (LISCO), KU Leuven, Leuven, Belgium.ORCID http://orcid.org/0000-0003-2273-2782
Cankat ErtekinDepartment of Development and Regeneration, Leuven Stem Cell Institute, Leuven Institute for Single Cell Omics (LISCO), KU Leuven, Leuven, Belgium.
Lotte VanheerDepartment of Development and Regeneration, Leuven Stem Cell Institute, Leuven Institute for Single Cell Omics (LISCO), KU Leuven, Leuven, Belgium.
Paraskevi AthanasouliDepartment of Development and Regeneration, Leuven Stem Cell Institute, Leuven Institute for Single Cell Omics (LISCO), KU Leuven, Leuven, Belgium.
Frederic LluisDepartment of Development and Regeneration, Leuven Stem Cell Institute, Leuven Institute for Single Cell Omics (LISCO), KU Leuven, Leuven, Belgium.
Dieter DeforceProGenTomics, Laboratory of Pharmaceutical Biotechnology, Ghent University, Ghent, Belgium.ORCID http://orcid.org/0000-0002-0635-661X
Joop H JansenLaboratory of Hematology, Department of Laboratory Medicine, Radboud University Nijmegen Medical Centre (RadboudUMC), Nijmegen, the Netherlands.
Benjamin A GarciaEpigenetics Institute, Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Michiel VermeulenDepartment of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences (RIMLS), Oncode Institute, Radboud University Nijmegen, Nijmegen, The Netherlands.ORCID http://orcid.org/0000-0003-0836-6894
Nicolas RivronInstitute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria.ORCID http://orcid.org/0000-0003-1590-5964
Maarten DhaenensProGenTomics, Laboratory of Pharmaceutical Biotechnology, Ghent University, Ghent, Belgium. Maarten.Dhaenens@UGent.be.ORCID http://orcid.org/0000-0002-9801-3509
Hendrik MarksDepartment of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University Nijmegen, Nijmegen, The Netherlands. Hendrik.Marks@ru.nl.ORCID http://orcid.org/0000-0002-4198-3731
Peter J Rugg-GunnEpigenetics Programme, Babraham Institute, Cambridge, UK. peter.rugg-gunn@babraham.ac.uk.ORCID http://orcid.org/0000-0002-9601-5949
Vincent PasqueDepartment of Development and Regeneration, Leuven Stem Cell Institute, Leuven Institute for Single Cell Omics (LISCO), KU Leuven, Leuven, Belgium. vincent.pasque@kuleuven.be.ORCID http://orcid.org/0000-0002-5129-0146
KU Leuven · BEBabraham Institute · GBRadboud University Nijmegen · NLGhent University · BEInstitute of Molecular Biotechnology · ATUniversity of Pennsylvania · USVIB-KU Leuven Center for Brain & Disease Research · BEVIB-KU Leuven Center for Microbiology · BE

Funding

STRUCTURAL BASIS FOR EPIGENETICS IN AGING AND LONGEVITYP01AG031862 · NIA · WISTAR INSTITUTE · PI ZHANG, RUGANG · 2008 to 2022
$28.3M
Shared Resources Core 2: Quantitative Proteomics CoreP01CA196539 · NCI · ROCKEFELLER UNIVERSITY · PI YOUNG, MICHAEL WARREN · 2015 to 2024
$17.6M
Viral modulation of epitranscriptomic mechanismsR01AI118891 · NIAID · WASHINGTON UNIVERSITY · PI GARCIA, BENJAMIN A, WEITZMAN, MATTHEW D. · 2015 to 2025
$5.4M
Biotechnology and Biological Sciences Research Council BBS/E/B/000C0421Biotechnology and Biological Sciences Research Council BBS/E/B/000C0422Medical Research Council MR/J003808/1Medical Research Council MR/N018419/1Medical Research Council MR/T011769/1Medical Research Council MR/V02969X/1NCI NIH HHS P01 CA196539NIAID NIH HHS R01 AI118891NIA NIH HHS P01 AG031862Wellcome TrustWellcome Trust 102160/Z/13/ZWellcome Trust 215116/Z/18/Z
6 · The paper itself

Abstract

Human naive pluripotent stem cells have unrestricted lineage potential. Underpinning this property, naive cells are thought to lack chromatin-based lineage barriers. However, this assumption has not been tested. Here we define the chromatin-associated proteome, histone post-translational modifications and transcriptome of human naive and primed pluripotent stem cells. Our integrated analysis reveals differences in the relative abundance and activities of distinct chromatin modules. We identify a strong enrichment of polycomb repressive complex 2 (PRC2)-associated H3K27me3 in the chromatin of naive pluripotent stem cells and H3K27me3 enrichment at promoters of lineage-determining genes, including trophoblast regulators. PRC2 activity acts as a chromatin barrier restricting the differentiation of naive cells towards the trophoblast lineage, whereas inhibition of PRC2 promotes trophoblast-fate induction and cavity formation in human blastoids. Together, our results establish that human naive pluripotent stem cells are not epigenetically unrestricted, but instead possess chromatin mechanisms that oppose the induction of alternative cell fates.

Indexed as

Pluripotent Stem CellsPolycomb Repressive Complex 2Cell DifferentiationChromatinHistonesHumansTrophoblastsChromatinHistonesPolycomb Repressive Complex 2

Identifiers

PMID35697783
PMCPMC9203278
OpenAlexW4282582236

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.